|
|
||||||||

* Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN 46202; and
Division of Molecular Cell Biology Paul Scherrer Institute, Basel, Switzerland
The number of alveolar macrophages is decreased in patients or animals with Pneumocystis pneumonia (Pcp). This loss of alveolar macrophages is in part due to apoptosis caused by Pneumocystis infection. The mechanism of apoptosis induction is unknown. Cell-free bronchoalveolar lavage fluids from Pneumocystis-infected rats or mice have the ability to induce apoptosis in normal alveolar macrophages. To characterize the mechanisms by which apoptosis proceeds in alveolar macrophages during Pcp, specific caspase inhibitors are tested for their ability to suppress the apoptosis. In vitro induction of apoptosis can be inhibited by the caspase-9 inhibitor (Z-LEHD-FMK) but not by the inhibitor to caspase-8 or -10. The caspase-9 inhibitor can also inhibit apoptosis of alveolar macrophages in vivo when it is intranasally instilled into dexamethasone-immunosuppressed, Pneumocystis-infected rats or L3T4 cell-depleted, Pneumocystis-infected mice. The number of alveolar macrophages rebounds in caspase-9 inhibitor-treated Pcp animals. Phagocytic activity of alveolar macrophages in treated animals is also recovered, and organism burden in these animals is reduced. Administration of caspase-9 inhibitor also clears the exudate that normally fills the alveoli during Pcp and decreases lung inflammation. Furthermore, caspase-9-treated Pcp animals survive for the entire 70-day period of the study, whereas nontreated Pcp animals die 4060 days after initiation of infection. Depletion of recovered alveolar macrophages by intranasal administration of clodronate-containing liposomes in caspase-9 inhibitor-treated animals abrogates the effects of the inhibitor. Together, these results indicate that immunomodulation of the host response may be an alternative to current treatments for Pcp.
This article has been cited by other articles:
![]() |
A. K. Pandey and A. Sodhi Recombinant YopJ induces apoptosis in murine peritoneal macrophages in vitro: involvement of mitochondrial death pathway Int. Immunol., November 1, 2009; 21(11): 1239 - 1249. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Lasbury, P. J. Durant, C.-P. Liao, and C.-H. Lee Effects of Decreased Calmodulin Protein on the Survival Mechanisms of Alveolar Macrophages during Pneumocystis Pneumonia Infect. Immun., August 1, 2009; 77(8): 3344 - 3354. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-P. Liao, M. E. Lasbury, S.-H. Wang, C. Zhang, P. J. Durant, Y. Murakami, S. Matsufuji, and C.-H. Lee Pneumocystis Mediates Overexpression of Antizyme Inhibitor Resulting in Increased Polyamine Levels and Apoptosis in Alveolar Macrophages J. Biol. Chem., March 20, 2009; 284(12): 8174 - 8184. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Beck, A. M. Preston, S. E. Wilcoxen, S. B. Morris, A. Sturrock, and R. Paine III Critical Roles of Inflammation and Apoptosis in Improved Survival in a Model of Hyperoxia-Induced Acute Lung Injury in Pneumocystis murina-Infected Mice Infect. Immun., March 1, 2009; 77(3): 1053 - 1060. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Winter, K. Taut, F. Langer, M. Mack, D. E. Briles, J. C. Paton, R. Maus, M. Srivastava, T. Welte, and U. A. Maus FMS-Like Tyrosine Kinase 3 Ligand Aggravates the Lung Inflammatory Response to Streptococcus pneumoniae Infection in Mice: Role of Dendritic Cells J. Immunol., September 1, 2007; 179(5): 3099 - 3108. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Lasbury, S. Merali, P. J. Durant, D. Tschang, C. A. Ray, and C.-H. Lee Polyamine-mediated Apoptosis of Alveolar Macrophages during Pneumocystis Pneumonia J. Biol. Chem., April 13, 2007; 282(15): 11009 - 11020. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Rapaka, E. S. Goetzman, M. Zheng, J. Vockley, L. McKinley, J. K. Kolls, and C. Steele Enhanced Defense against Pneumocystis carinii Mediated by a Novel Dectin-1 Receptor Fc Fusion Protein J. Immunol., March 15, 2007; 178(6): 3702 - 3712. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |